REM Sleep Behavior Disorder EEG MCQ — NEET PG Practice Question | NEETPGAI
REM Sleep Behavior Disorder EEG
medium
brain Psychiatry
A 62-year-old man presents to the sleep clinic with a 2-year history of violent nocturnal behaviour during which he punches, kicks, and shouts while asleep. His wife reports he appears to be "acting out his dreams" and has sustained a laceration to her arm during one episode. Polysomnography is performed. The EEG shows normal sleep architecture, but the structure marked **A** in the diagram is identified — persistent submental EMG tone during REM sleep with excessive phasic chin and limb EMG twitches. Which of the following is the most important long-term prognostic counselling point for this patient?
A. The patient will develop obstructive sleep apnoea within 5 years and requires immediate CPAP therapy
B. The condition is benign and self-limiting; symptoms typically resolve within 2–3 years with lifestyle modification alone
C. Over 80% of patients with idiopathic RBD will develop a synucleinopathy such as Parkinson disease, Lewy body dementia, or multiple system atrophy within 10–15 years
D. RBD is a permanent primary sleep disorder unrelated to neurodegenerative disease; long-term prognosis depends only on bedroom safety measures
Explanation
Why "Over 80% of patients with idiopathic RBD will develop a synucleinopathy..." is right
The clinical anchor defines RBD as a prodromal alpha-synucleinopathy. The finding of loss of REM-sleep muscle atonia (marked A — persistent submental EMG tone during REM) is the polysomnographic hallmark of RBD. The ICSD-3 diagnostic criteria require demonstration of REM sleep without atonia (RSWA) on PSG. The critical prognostic fact is that idiopathic RBD is not a benign parasomnia but rather a preclinical marker of neurodegeneration: more than 80% of patients will develop Parkinson disease, Lewy body dementia, or multiple system atrophy within 10–15 years. This is the cornerstone of modern RBD counselling and justifies enrolment in prodromal synucleinopathy cohorts and serial follow-up for hyposmia, orthostatic dysautonomia, constipation, and subtle motor signs (Postuma et al Brain 2019; AASM ICSD-3).
Why each distractor is wrong
"The condition is benign and self-limiting; symptoms typically resolve within 2–3 years with lifestyle modification alone": RBD is not self-limiting. It is a chronic parasomnia with a progressive underlying neurodegenerative substrate. Symptoms persist and may worsen over time as the synucleinopathy advances.
"RBD is a permanent primary sleep disorder unrelated to neurodegenerative disease; long-term prognosis depends only on bedroom safety measures": This directly contradicts the anchor. RBD is explicitly a prodromal synucleinopathy, not an isolated sleep disorder. While bedroom safety is essential for acute harm prevention, the long-term prognosis is dominated by the risk of overt neurodegeneration.
"The patient will develop obstructive sleep apnoea within 5 years and requires immediate CPAP therapy": There is no evidence that RBD inevitably leads to OSA, nor is CPAP a standard management for RBD. This conflates two separate sleep disorders and is not supported by the diagnostic criteria or prognostic literature.
High-YieldNEET PG
Idiopathic RBD is a red flag for future Parkinson disease or Lewy body dementia — counsel all patients accordingly and arrange prodromal follow-up.
AASM ICSD-3 Diagnostic Criteria; Postuma et al Brain 2019
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.